ReShape Lifesciences (RSLS)
NASDAQ:RSLS
Holding RSLS?
Track your performance easily

ReShape Lifesciences (RSLS) Income Statement

464 Followers

ReShape Lifesciences Income Statement

Last quarter (Q2 2024), ReShape Lifesciences's total revenue was $1.97M, a decrease of -12.82% from the same quarter last year. In Q2, ReShape Lifesciences's net income was $-1.59M. See ReShape Lifesciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 8.05M$ 8.68M$ 11.24M$ 13.60M$ 11.30M$ 15.09M
Cost of Revenue
$ 2.62M$ 3.13M$ 4.44M$ 5.25M$ 5.04M$ 5.78M
Gross Profit
$ 5.43M$ 5.55M$ 6.80M$ 8.35M$ 6.26M$ 9.30M
Operating Expense
$ 15.47M$ 20.93M$ 53.15M$ 66.23M$ 18.72M$ 33.77M
Operating Income
$ -10.04M$ -15.38M$ -46.35M$ -57.88M$ -12.46M$ -15.89M
Net Non Operating Interest Income Expense
$ 35.00K$ 26.00K$ -113.00K$ -832.00K$ -2.05M$ -451.00K
Other Income Expense
$ 6.22M$ 3.28M$ -19.40M$ 2.06M$ 7.71M$ 1.89M
Pretax Income
$ -8.96M$ -11.34M$ -46.59M$ -63.42M$ -21.81M$ -75.10M
Tax Provision
$ 63.00K$ 52.00K$ -380.00K$ -274.00K$ -181.00K$ -893.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -9.02M$ -11.39M$ -46.21M$ -63.15M$ -21.63M$ -74.21M
Basic EPS
$ -0.96$ -1.91$ -6.32K$ -14.50K$ -27.14K$ -373.49K
Diluted EPS
$ -0.96$ -1.91$ -6.32K$ -14.50K$ -27.14K$ -373.49K
Basic Average Shares
$ 67.55M$ 5.96M$ 7.32K$ 4.27K$ 796.00$ 198.00
Diluted Average Shares
$ 67.55M$ 5.96M$ 7.32K$ 4.27K$ 796.00$ 198.00
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 18.09M$ 23.32M$ 57.59M$ 71.48M$ 23.76M$ 39.55M
Net Income From Continuing And Discontinued Operation
$ -9.02M$ -11.39M$ -46.21M$ -63.15M$ -21.63M$ -23.68M
Normalized Income
$ -7.05M$ -8.21M-$ -2.40M--
Interest Expense
------
EBIT
$ -8.76M$ -14.64M$ -46.48M$ -62.59M$ -19.76M$ -75.10M
EBITDA
$ -8.69M$ -14.48M$ -44.35M$ -60.62M$ -18.09M$ -72.43M
Currency in USD

ReShape Lifesciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis